|
|
Enron Mail |
Please call him.
=20 =09 =09 =09From: Kathleen Carnahan 11/07/2000 09:49 AM =09 To: Kay Mann/Corp/Enron@Enron cc: =20 Subject: Re: Draft CA for curves =20 You got it. Did Gregg happen to mention which legal entity of Peoples is= =20 using the confidential information? I can call him if you want me to. I'll make the first set of changes right now and wait to hear from you abou= t=20 the length of the effective period. K- Kay Mann 11/07/2000 09:43 AM To: Kathleen Carnahan/NA/Enron@Enron cc: =20 Subject: Re: Draft CA for curves =20 Kathleen, Please change the first paragraph as follows: ENA is prepared to furnish you with certain risk analysis information which= =20 is either confidential, proprietary or generally not available to the publi= c=20 ("Confidential Information") in connection with ENA=01,s disclosure to PERC= =20 and/or enovate for its performing independent risk analysis relating to of= =20 the portfolio of enovate, L.L.C., a Delaware limited liability company. Suc= h=20 information may include (but not be limited to) and for PERC=01,s evaluatio= n of=20 daily curves such as price, basis, index, volitility and interest rates as= =20 they relate to the operations of enovate, L.L.C. As a condition to=20 furnishing Confidential Information, PERC and ENA each agree to the followi= ng: As for the paragraph 7, I've asked Gregg if the disclosures will be one tim= e,=20 or ongoing. If the disclosures will be ongoing, we may want to rethink the= =20 effective period to make it two years from the last disclosure. Gregg also needs a resoluting regarding signing authority, but I've left hi= m=20 a voice mail asking for more information. Thanks, Kay =20 =09 =09 =09From: Kathleen Carnahan 11/06/2000 09:13 AM =09 To: Kay Mann/Corp/Enron@Enron cc: =20 Subject: Draft CA for curves Attached is a draft of the CA for Peoples based on Gregg Penman's informati= on=20 below. Gregg says he also wants some language to be included regarding aud= it=20 rights. I did not include this language because I'm not sure how to word i= t=20 (and I could not find an example). By the way, I used another People's CA I got from Ed's directory as an=20 example because it seemed to fit better than the one I got from you on Frid= ay. Gregg wanted some pretty specific reference to the confidential data being= =20 supplied to Peoples, and most of the examples I reviewed were more general.= =20 Please let me know what I need to change. Kathleen This is the example I used: ---------------------- Forwarded by Kathleen Carnahan/NA/Enron on 11/06/200= 0=20 09:02 AM --------------------------- To: Kathleen Carnahan/NA/Enron@Enron, Kay Young/HOU/ECT@ECT cc: =20 Subject: Draft CA for curves Kathleen, We have forms for confidentiality agreements. All CA's are processed throu= gh=20 Kay Young, as she maintains the data base. Kay, could you point Kathleen t= o=20 the repository of the forms so that she can generate the first draft? By th= e=20 way, I've assembled the emails I received on changing the form. I'll be=20 happy to take a crack at the revisions if you tell me which form to start= =20 with. I know it will have to be processed through before it becomes standa= rd. Thanks, Kay ---------------------- Forwarded by Kay Mann/Corp/Enron on 10/24/2000 08:56= =20 AM --------------------------- From: Gregg Penman on 10/23/2000 10:28 AM To: Kay Mann/Corp/Enron@Enron cc: =20 Subject: Draft CA for curves Kay - We have previously discussed the idea of a CA to specifically cover t= he=20 curves. We need to put this at the top of the list for this week. Can you= =20 prepare a CA for the distribution of enovate curves to specific individuals= =20 at Peoples? I would like it to read as follows: Basis and Index curves will be provided daily for all points at which enova= te=20 has a position, whether hedged or open, to specific individuals employed in= =20 the risk management area. (Individuals should be named on a schedule). Curves are being provided for the express purpose of independent risk=20 analysis of the enovate portfolio by Peoples Risk Management personnel. = =20 In return, the specific individuals will not forward, copy, or otherwise=20 distribute the curves to any individual not on the approved schedule. No= =20 communications, written or verbal, will be made to any person other than th= e=20 enovate GM or the Enron designated enovate risk committee member regarding= =20 any aspect of the curves. =20 I need some language regarding audit rights, but this should get you=20 started. Call me to discuss. Gregg ---------------------- Forwarded by Kathleen Carnahan/NA/Enron on 11/06/200= 0=20 09:02 AM --------------------------- From: Gregg Penman on 11/01/2000 03:13 PM To: Kathleen Carnahan/NA/Enron@Enron cc: Kay Mann/Corp/Enron@Enron=20 Subject: CA for enovate Kathleen - As we discussed, here is a high level overview of what I am tryi= ng=20 to accomplish. =20 Purpose: Employees and representatives of Peoples Energy will be provided= =20 information related to the operations of enovate, L.L.C. that is necessary = or=20 appropriate to review the accuracy of data and verify that the operations a= nd=20 controls set forth in Section VIII of the enovate, L.L.C. Risk Management= =20 Policy are being properly implemented and followed. Information may includ= e=20 forward curves such as price, basis, index,volatility and interest rates to= =20 the extent they relate to the operations of enovate, L.L.C.=20 Restrictions: All information provided is deemed confidential. Informatio= n=20 provided may only be used for the purpose mentioned above. None of the=20 provided information may be distributed or communicated to any person who i= s=20 not subject to the confidentiality agreement. Call me with any questions you may have. Thank you for your assistance. Gregg
|